Dr Amina Al-Yassin: key facts
- Kind of voice
- Clinician
- Role
- Clinical Lead for Children and Young People's Services at Brent Integrated Care Partnership
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“They make people feel better, but only briefly. We now know that over time they are likely to make asthma worse. Seeing a blue inhaler used alone is now a dangerous sign to me… The blue inhaler or SABA was the mainstay of asthma treatment for years, but that has changed. There is a big attitude shift. The NICE guideline gave us the confidence we needed to strongly recommend this change to our patients.”
What Dr Amina Al-Yassin has said
“'We now know that over time they are likely to make asthma worse. Seeing a blue inhaler used alone is now a dangerous sign to me.'”
GP and clinical lead for children and young people's services at Brent Integrated Care Partnership · Respiratory (asthma/COPD) · 10 Sept 2026 · Over one million switched to combined asthma inhalers since NICE update ↗
Where Dr Amina Al-Yassin has been quoted
- Shift in asthma treatment culture with more than a million people switching to new inhalersnationalhealthexecutive.com · 30 Sept 2026
- Over one million switched to combined asthma inhalers since NICE updatepulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.